Additional Xarelto Lawsuit Filings Expected As Litigation Moves Forward In MDL

June 24, 2016 – – TheProductLawyers.com reports on the selection of cases for the multidistrict litigation (MDL 2592) against Xarelto. The individual cases number over 2,000 and bring similar allegations against the new-generation anticoagulant and it’s manufacturers—Bayer AG and Janssen Pharmaceuticals. Presiding over the MDL in the Eastern District of Louisiana is Judge Eldon Fallon.

Even though it was originally hailed as a breakthrough in the treatment and prevention of blood clots and the attendant complications, such as strokes, critics of the drug have called it the most dangerous blood thinner on the market to date. It was released for use without an antidote, which, in the instance of complications, is essential.

Because other, more established anticoagulant drugs act differently from Xarelto—a fact that initially brought positive attention to the new-generation drug—doctors can easily treat a bleeding event. By treating a patient with the antidote of vitamin K, physicians reverse the blood-thinning action of traditional anticoagulants and allow the body to heal itself. While mobile clots within the circulatory system can be harmful or even fatal, the body must be able to close wounds, which it does by patching the breach with platelets. Blood thinners prevent this action, no matter where in the body it might occur. Without an antidote, even relatively minor bleeding events can quickly become catastrophic and potentially fatal.

For patients who were using Xarelto, doctors had to consider drastic or invasive procedures, such as surgery, in the event that they began to bleed. Several plaintiffs claim in their lawsuits that the manufacturers of Xarelto were negligent in allowing the drug to be approved, released, and aggressively marketed without such an antidote for so long.

Although selection for bellwether case took place earlier this year, the additional information these proceedings have brought to light will continue to spread. Individuals who may have suffered harm as a result of taking the anticoagulant are likely to seek damages as this case progresses.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010998